What is Tagrisso
Approved as Treatment by the FDA
Osimertinib, also known as Tagrisso, is approved by the FDA for 5 uses which include Chemotherapy and Failed Tyrosine Kinase Inhibitors .Effectiveness
When to interrupt dosage
The prescribed dosage of Tagrisso is dependent on the diagnosed condition. The exact amount varies, in accordance with the method of administration specified in the table below.Warnings
There are 20 known major drug interactions with Tagrisso.Tagrisso Novel Uses: Which Conditions Have a Clinical Trial Featuring Tagrisso?
Nine active clinical trials are presently underway to evaluate the potential of Tagrisso in treating Malignant Neoplasms.Tagrisso Reviews: What are patients saying about Tagrisso?
Patient Q&A Section about tagrisso
Can Tagrisso cure lung cancer?
"AstraZeneca's Tagrisso has been approved by the US Food and Drug Administration (FDA) for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after tumour resection with curative intent." - Anonymous Online Contributor
What kind of cancer does Tagrisso treat?
"Tagrisso is a cancer medication used to treat non-small cell lung cancer (NSCLC). It is specifically used to treat patients whose cancer cells have certain mutations in the EGFR gene." - Anonymous Online Contributor
Is Tagrisso a form of chemotherapy?
"TAGRISSO is a targeted cancer therapy in pill form that is taken once a day, with or without food. Targeted cancer therapies are designed specifically to target certain types of cancer and work by blocking the growth and spread of cancer cells." - Anonymous Online Contributor